Inactive Instrument
Centrexion Therapeutics Corporation Stock
Stocks
CNTX
US15643W1009
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
James Campbell
PSD | President | 78 | 2013-01-31 |
Jeffrey Kindler
CEO | Chief Executive Officer | 70 | 2013-09-30 |
| Chief Tech/Sci/R&D Officer | - | 2015-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sol Barer
CHM | Chairman | 78 | 2013-01-31 |
Jeffrey Kindler
BRD | Director/Board Member | 70 | 2013-09-30 |
| Director/Board Member | 85 | 2013-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 0 | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 66.37B | ||
| +1.85% | -0.78% | +10.14% | +92.72% | 58.86B | ||
| +1.03% | +0.90% | +26.53% | +87.46% | 55.22B | ||
| -1.13% | -2.53% | +9.73% | +121.14% | 47.21B | ||
| +0.84% | -6.38% | +19.19% | +25.79% | 42.45B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.44B | ||
| -0.66% | -15.73% | +135.31% | +662.73% | 35.19B | ||
| +0.84% | -1.01% | +83.98% | +58.78% | 32.66B | ||
| -0.35% | +1.98% | -38.27% | +390.98% | 26.73B | ||
| Average | +0.22% | -2.29% | +35.57% | +172.86% | 45B | |
| Weighted average by Cap. | +0.42% | -2.18% | +35.32% | +147.47% |
Employees
24
















